Evidence-Based Complementary and Alternative Medicine / 2018 / Article / Tab 2

Review Article

Xuebijing Injection Combined with Antibiotics for the Treatment of Spontaneous Bacterial Peritonitis in Liver Cirrhosis: A Meta-Analysis

Table 2

Characteristics of patients.

First author (year)Number of ptsEtiology of liver diseaseSex (male/female) ()Age (mean)GroupsFollow-up (days)Overall response ()Complete response ()No response ()

Sheng (2017)34NA36/3236.90XBJ group731163<0.05
34NAControl group725109

Yuan (2015)45NA36/953.50XBJ group1040255<0.05
40NA32/852.30Control group10271813

Wang (2015)44NA23/2137.85XBJ group740274<0.05
44NA22/2237.92Control group7331511

Zhang (2014)32HBV 3218/1450.12XBJ group2828204<0.05
3218/1451.21Control group28221010

Shu (2011)32HBV 49; HCV 7;
alcohol 5; PBC 3; cryptogenic cirrhosis 2
54/1233.92XBJ group1428104<0.05
34Control group1424810

Zhang (2010)90Posthepatitic cirrhosis 73;
alcohol 9; PBC 5;
cryptogenic cirrhosis 3
62/2847.20XBJ group78387 <0.05
78Posthepatitic cirrhosis 67;
alcohol 7; PBC 3;
cryptogenic cirrhosis 1
61/1748.10Control group763215

Wang (2010)30HBV 36; HCV 5;
alcohol 14; PBC 2; unknown origin 3
47/1351.38XBJ group728202<0.05
30Control group721149

Jing (2010)32NA23/949.30XBJ group729223<0.05
28NA21/748.70Control group722136

Gao (2009)45NA38/748.30XBJ group10352510>0.05
40NA35/546.20Control group10271813

Pts, patients; XBJ, Xuebijing injection; HBV, hepatitis B virus; HCV, hepatitis C virus; PBC, primary biliary cirrhosis.